BMS and Pfizer to collaborate on Thrombotic and Metabolic Disorders
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 84 (Table of Contents)
Published: 7 Jun-2007
DOI: 10.3833/pdr.v2007.i84.328 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Bristol-Myers Squibb and Pfizer entered into exclusive worldwide collaboration to develop and commercialize the anticoagulant apixaban, which is in different clinical trials for treating arterial and venous thrombotic conditions...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS